Koch BCP - Search Results

1

Exploring P-gp as moderator of side effects and effectiveness of risperidone in children and adolescents.

Hermans RA, Gangapersad RN, Kloosterboer SM, van Schaik RHN, Hillegers MHJ, Koch BCP, de Winter BCM, Dierckx B. Hermans RA, et al. Among authors: koch bcp. Eur Neuropsychopharmacol. 2024 Apr 20;85:5-7. doi: 10.1016/j.euroneuro.2024.04.002. Online ahead of print. Eur Neuropsychopharmacol. 2024. PMID: 38643629 No abstract available.

2

Correction to: Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines.

Van Vyve L, Dierckx B, Lim CG, Danckaerts M, Koch BCP, Häge A, Banaschewski T. Van Vyve L, et al. Among authors: koch bcp. Eur J Pediatr. 2024 Mar;183(3):1057. doi: 10.1007/s00431-024-05426-5. Eur J Pediatr. 2024. PMID: 38277002 No abstract available.

3

Nitrofurantoin for the treatment of uncomplicated urinary tract infection in female patients: the impact of dosing regimen, age, and renal function on drug exposure.

van Driel AA, Muller AE, Wijma RA, Stobberingh EE, Verbon A, Koch BCP. van Driel AA, et al. Among authors: koch bcp. Eur J Clin Pharmacol. 2023 Aug;79(8):1043-1049. doi: 10.1007/s00228-023-03507-2. Epub 2023 Jun 2. Eur J Clin Pharmacol. 2023. PMID: 37266591 Free PMC article.

4

Quantification of vancomycin and clindamycin in human plasma and synovial fluid applying ultra-performance liquid chromatography tandem mass spectrometry.

Ringeling LT, Bahmany S, van Oldenrijk J, Bos PK, Veltman ES, Koch BCP. Ringeling LT, et al. Among authors: koch bcp. J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Dec 1;1212:123493. doi: 10.1016/j.jchromb.2022.123493. Epub 2022 Oct 13. J Chromatogr B Analyt Technol Biomed Life Sci. 2022. PMID: 36283258 Free article.

5

Reply to 'optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension'.

Peeters LEJ, Koch BCP, Versmissen J. Peeters LEJ, et al. Among authors: koch bcp. J Hypertens. 2024 Jun 1;42(6):1106-1107. doi: 10.1097/HJH.0000000000003724. Epub 2024 May 1. J Hypertens. 2024. PMID: 38690910 No abstract available.

6

Pharmacokinetics and Pharmacodynamics of Intravenous Immunoglobulin G Maintenance Therapy in Chronic Immune-mediated Neuropathies.

Fokkink W, Koch B, Ramakers C, van Doorn PA, van Gelder T, Jacobs BC. Fokkink W, et al. Among authors: koch b. Clin Pharmacol Ther. 2017 Oct;102(4):709-716. doi: 10.1002/cpt.693. Epub 2017 Jun 5. Clin Pharmacol Ther. 2017. PMID: 28378901

7

Failure of target attainment for beta-lactam antibiotics and ciprofloxacin in acute brain-injured intensive care patients.

Ergezen S, Ewoldt TMJ, van der Jagt M, Koch BCP, Endeman H; DOLPHIN Investigators. Ergezen S, et al. Among authors: koch bcp. Intensive Care Med. 2024 May 8. doi: 10.1007/s00134-024-07459-8. Online ahead of print. Intensive Care Med. 2024. PMID: 38717647 No abstract available.

8

Correction to: Comparison of antipsychotic drug use in children and adolescents in the Netherlands before and during the COVID-19 pandemic.

Gangapersad RN, Zhou G, Garcia-Gomez P, Bos J, Hak E, Koch BCP, Schuiling-Veninga CCM, Dierckx B. Gangapersad RN, et al. Among authors: koch bcp. Eur Child Adolesc Psychiatry. 2024 Apr 20. doi: 10.1007/s00787-024-02434-6. Online ahead of print. Eur Child Adolesc Psychiatry. 2024. PMID: 38642119 No abstract available.

9

Population pharmacokinetics of intraperitoneal irinotecan and SN-38 in patients with peritoneal metastases from colorectal origin.

Rietveld PCS, Sassen SDT, Guchelaar NAD, van Eerden RAG, de Boer NL, van den Heuvel TBM, Burger JWA, Mathijssen RHJ, Koch BCP, Koolen SLW. Rietveld PCS, et al. Among authors: koch bcp. CPT Pharmacometrics Syst Pharmacol. 2024 Apr 17. doi: 10.1002/psp4.13136. Online ahead of print. CPT Pharmacometrics Syst Pharmacol. 2024. PMID: 38634204 Free article.

10

Towards optimizing cefepime/tazobactam (WCK 4282) exposure to achieve efficacy against piperacillin/tazobactam-resistant ESBL infections: dose recommendations for various renal functions, including intermittent haemodialysis, in healthy individuals.

Muller AE, De Winter BCM, Koch BCP. Muller AE, et al. Among authors: koch bcp. J Antimicrob Chemother. 2024 May 2;79(5):1093-1100. doi: 10.1093/jac/dkae076. J Antimicrob Chemother. 2024. PMID: 38507250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page